Pioneering Innovative API manufacturing solutions

Delivering excellence in Active Pharmaceutical Ingredients and formulations
through innovation, compliance, and sustainability.

Who We Are

Redun Pharma LLP is a
Research-Driven Pharmaceutical Manufacturer

Specialising in the production and contract development of Active Pharmaceutical Ingredients (APIs) and finished formulations.

Founded with the vision to contribute to India’s self-reliant pharmaceutical growth, we began as a collaborative initiative to bring together deep chemical engineering expertise and modern API manufacturing capabilities.

Our
Journey

Our
Capabilities & Expertise

Our

Products

Sacubitril Sodium

Therapeutic Class:
Cardiovascular / Heart Failure

Description:

Sacubitril Sodium, marketed as an API by Redun, is formulated in combination with Valsartan to create a widely used therapy for chronic heart failure. Commercially known as Entresto, this combination medication is designed to reduce the risk of hospitalisation and cardiovascular death while improving overall patient outcomes.

Key Highlights:

  • Used in combination with Valsartan for effective heart failure management
  • Clinically proven to reduce hospitalisation and cardiovascular mortality
  • Supports improved cardiac function and long-term patient outcomes
  • Manufactured under stringent quality standards ensuring consistency and reliability
1

Sacubitril Valsartan Trisodium

Therapeutic Class:
Cardiovascular / Heart Failure

Description:

Sacubitril Valsartan Trisodium, marketed by Redun as an API for formulators, is used in the development of combination therapies for chronic heart failure. Commercially known under the brand name Entresto when formulated appropriately, this medication helps reduce the risk of hospitalisation and cardiovascular death while improving patient outcomes.

Key Highlights:

  • Marketed as an API for formulation of Sacubitril/Valsartan combination therapy
  • Supports effective management of chronic heart failure
  • Clinically associated with reduced hospitalisation and cardiovascular mortality
  • Manufactured under stringent quality standards ensuring purity and consistency
APRIL SM_2026 (2) 3

Dorzolamide

Therapeutic Class:
Ophthalmic Glaucoma & Ocular Hypertension

Description:

Dorzolamide is an ophthalmic medication designed to lower intraocular pressure in individuals with open-angle glaucoma or ocular hypertension. It works by reducing fluid production in the eye, thereby preventing optic nerve damage.

Key Highlights:

  • Fast onset of action – effects seen within 3 hours 
  • Long-lasting pressure control for up to 8 hours 
  • Available for use as a standalone or combination formulation
2

Nebivolol Hydrochloride

Therapeutic Class:
Cardiovascular / Hypertension

Description:

Nebivolol is a beta-blocker primarily used to treat high blood pressure and heart failure. It helps relax blood vessels, reducing the risk of stroke, heart attack, and other cardiac complications.

Key Highlights:

  • Promotes smooth blood flow and optimal cardiac performance 
  • Suitable for monotherapy or combination therapy 
  • Tested for safety, efficacy, and stability under stringent quality systems 
4

Nepafenac

Therapeutic Class:
COphthalmic NSAID (Non-Steroidal Anti-Inflammatory Drug)

Description:

Nepafenac is a non-steroidal anti-inflammatory drug (NSAID) approved for ophthalmic use to treat pain and swelling of the eye following cataract surgery. Nepafenac is also chemically known as 2-amino-3-benzoylbenzeneacetamide and is structurally represented by the formula

Key Highlights:

  • Effective relief from post-operative ocular pain and inflammation
  • Rapid corneal penetration with targeted intraocular activation
  • Helps reduce prostaglandin-mediated inflammatory response
  • Suitable for use in post-cataract surgical care protocols
Redun Pharma op2

Our

Team

Mr. Gurumoorthy
Ramamoorthy

Founder & Managing Partner

Gurumoorthy is a distinguished Chemical Engineer and an alumnus of the Indian Institute of Technology, Madras.

A seasoned industry professional, Gurumoorthy has held senior leadership roles across reputed organizations including Jayant Vitamins Ltd, Galaxy Organics Ltd, Loctite India Pvt. Ltd (a subsidiary of Loctite Corporation, USA), and Asian Paints Ltd.

With his extensive global experience, he brings a unique blend of technical expertise, operational insight, and strategic leadership to every endeavor.

Mr. Rajesh
Gurumoorthy

Co-Founder & Partner

Rajesh has an MBA from Rollins College, Orlando, FL. An avid long-distance runner, he has completed several half marathons.

Rajesh is a risk management and shared services professional with over 20 years’ experience in Financial Services, Insurance, Working Capital Management & BPO.

As the Founder-CEO of niche insurance underwriting technology and back-office services company, he has been providing strategic leadership and direction for the last 15+ years to a team of 200+ professionals.

 

Rajesh has an MBA from Rollins College, Orlando, FL. An avid long-distance runner, he has completed several half marathons.

Rajesh is a risk management and shared services professional with over 20 years’ experience in Financial Services, Insurance, Working Capital Management & BPO.

As the Founder-CEO of niche insurance underwriting technology and back-office services company, he has been providing strategic leadership and direction for the last 15+ years to a team of 200+ professionals.

 

Dr. Niranjan Gokhale

Research & Development

Sriparna

Quality Assurance

Sujit Save

Production

Seshadri
Chandrasekar

Marketing

Reimagine API
sourcing with Redun

We implement a rigorous Quality Control protocol, encompassing both in-process and final product testing.

GMP-certified production

NABL-validated QC for batch-to-batch consistency

Environment-friendly practices with minimum wastage

Atmanirbhar focus – minimising import dependence

High quality at optimum cost with on-time delivery

Experienced leadership & specialist team

Let’s build Reliable API supplies together.

Science. Quality. Trust
Built in every Batch.

Whether you’re seeking high-quality APIs, reliable contract manufacturing, or long-term collaboration, our team brings scientific expertise, global compliance, and on-time delivery to every partnership.

Share your molecule, volume, and timeline. Our team will respond with the best pathway from development to delivery.

Get in Touch

Head Office 
Redun Pharma LLP 
Peenya Industrial Area, Bangalore, India 

Additional Operations: 
J.P. Nagar, Bangalore 

12983846_5114854-01

Redun Pharma LLP is among the emerging API manufacturing companies in Bangalore, known for its GMP-certified facilities, NABL-validated quality control, and research-led approach.

Yes. Redun operates through its own R&D laboratory and collaborates with Beloor Bayir Chemicals, a GMP-certified facility in Peenya, Bangalore, for large-scale production. This ensures both innovation and reliability in API manufacturing. 

Redun’s portfolio includes Sacubitril Sodium & Sacubitril Valsartan Trisodium for cardio vascular care, Nebivolol Hydrochloride for hypertension and cardiac care, Nepafenac for anti-inflammatory ophthalmic care, and Dorzolamide for glaucoma and ocular hypertension. Each API is produced under strict quality and safety standards to ensure consistency and reliability. 

Every batch undergoes in-process and final testing, validated by a NABL-accredited laboratory. The company follows GMP-certified procedures, ensuring consistency, purity, and full regulatory compliance across all production stages.

Redun ensures transparent communication, competitive pricing, and on-time delivery for every partnership.